Meng Wu, Meng Wu, Jingyi Cui, Jingyi Cui, Huimin Hou, Ying Li, . . . Ming Liu. (2022). Novel MDM2 Inhibitor XR-2 Exerts Potent Anti-Tumor Efficacy and Overcomes Enzalutamide Resistance in Prostate Cancer. Frontiers Media S.A..
Chicago Style (17th ed.) CitationMeng Wu, et al. Novel MDM2 Inhibitor XR-2 Exerts Potent Anti-Tumor Efficacy and Overcomes Enzalutamide Resistance in Prostate Cancer. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationMeng Wu, et al. Novel MDM2 Inhibitor XR-2 Exerts Potent Anti-Tumor Efficacy and Overcomes Enzalutamide Resistance in Prostate Cancer. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.